MODIFICATION TO HYPOGUARD ADVANCE BLOOD GLUCOSE MONITORING SYSTEM— 510(k) K031388

Substantially Equivalent

Hypoguard USA, Inc.

FDA 510(k) clearance K031388 for MODIFICATION TO HYPOGUARD ADVANCE BLOOD GLUCOSE MONITORING SYSTEM, Substantially Equivalent on 2003-05-22. Applicant: Hypoguard USA, Inc..

Clearance details

Applicant: Hypoguard USA, Inc.
Product code: Code CGA
Advisory panel: Clinical Chemistry
Date received: 2003-05-02
Decision date: 2003-05-22
Decision: Substantially Equivalent
Clearance type: Special
Location: Edina, MN, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code CGA

product code CGA

Death: 2
Malfunction: 1,816
Total: 1,818

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.